For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Published Date: 08 Dec 2023

Transfusion is not necessary when using iptacopan, as it outperforms C5 Inhibitors in maintaining hemoglobin levels.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Survival rates for incurable larynx cancer investigated for first time

2.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

3.

Knowing about and avoiding bladder cancer.

4.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

5.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot